BELLEVILLE, ON, Oct. 7, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX:
BNC) (ASX: BNC), a research-based, technology-driven Canadian
biopharmaceutical company, today provided an update on its plans for a
New Drug Submission filing in Canada for Urocidin™, the Company's......
More...
